The Miami New Times will not hand over the Biogenesis files to Major League Baseball … because of Jeffrey Loria


The Miami New Times has realized that Major League Baseball is a business, not an arm of the government, and has decided not to hand over the records of the Biogenesis clinic to the league. But the best part of it all is one of the reasons: Jeff Loria.

The New Times — perhaps a little self-servingly, given that they have ripped Loria often in the past — details Loria’s history of mismanagement and bad deeds, notes that Bud Selig is supposed to act in the best interests of baseball, and that he has nonetheless enabled Loria for over a decade. They go on:

So this is the guy who wants our records? Isn’t he the same commissioner who in 2002 approved the complicated deal that gave Loria the Marlins, betrayed the City of Montreal, and caused Loria’s partners to accuse the artful merchant of racketeering? … he represents an organization with a long history of getting things wrong …

The New Times goes on to cite every transgression in baseball history — from the Black Sox on down — and says Major League Baseball is responsible. Then notes, specifically, that Selig was on watch while steroids flourished in baseball and guys like Mark McGwire continue to allowed to be part of the game, and worries that Selig may misuse the records to hand out uneven discipline or the like.

It’s all rather amusing, actually, even if the justifications for not handing them over which are attributable to baseball’s misdeeds are all over the map (really? Selig has to pay for the Black Sox scandal and segregation now?). And even if later in the editorial the New Times notes that the real reasons were journalistic ethics, worry about future leakers having their info and identity disseminated against their will and — this seems like the biggest reason — there is an ongoing state investigation into Anthony Bosch that the New Times feel will be imperiled if they hand over records to anyone else.

The important thing here, I think, is the result. It’s just bad form for a newspaper to hand over its investigative records to some private business. One which clearly has a conflict of interest to boot. So even if the New Times’ reasoning here is all rather, well, odd and funny, the right decision was reached.

2018 Preview: New York Mets

Rich Schultz/Getty Images
Leave a comment

Between now and Opening Day, HardballTalk will take a look at each of baseball’s 30 teams, asking the key questions, the not-so-key questions, and generally breaking down their chances for the 2018 season. Next up: The New York Mets.

Things couldn’t have gone much worse for the Mets in 2017, so the fact that they won 70 games is actually remarkable. Their hailed rotation was a shambles, as Noah Syndergaard made only seven starts. Zack Wheeler put up a 5.21 ERA over 17 starts; Matt Harvey was even worse with a 6.70 ERA across 18 starts and one relief appearance. Steven Matz compiled a 6.08 ERA in 13 starts. Just about the only consistency the club had came from Jacob deGrom, who finished with a career-high 3.53 ERA in 31 starts.

The rotation, as of right now, is healthy, save for deGrom, who has been battling a minor back issue during this spring. But so far, so good for everyone else. Well, there was Jason Vargas, who signed a two-year, $16 million deal with the Mets last month and suffered a non-displaced fracture of the hamate bone in his non-throwing hand. He underwent surgery and is expected to return shortly after the start of the regular season. But I mean, at least they still have everyone else!

Well, Michael Conforto is still recovering from shoulder surgery last September. The Mets are targeting May 1 for his return. That’s everyone, right? Wright? Where’s David Wright? The third baseman underwent two surgeries in September and October last year for his shoulder and back and still isn’t feeling well enough to play baseball, so the Mets shut him down for eight weeks.

The Mets haven’t had a legitimate full-time third baseman since 2014, Wright’s last full season. No Mets third baseman has played more than 55 games in a season at third base in the last three seasons. So the club went out and signed Todd Frazier to a two-year, $17 million contract. Frazier split last season with the White Sox and Yankees, hitting a combined .213/.344/.428 with 27 home runs and 76 RBI. While Frazier is now 32 years old and has seen a decline in power, he did set a career-high in walk rate last year at 14.4 percent and he’s still a solid defender. Frazier is still more than a capable player and he’ll look like a Greek god at the hot corner compared to what the Mets have trotted out there lately.

Shortstop at Citi Field now belongs to 22-year-old Amed Rosario. Among the top prospects in baseball, Rosario struggled last year, batting .248/.271/.394 across 46 games. Rosario has the most upside of any position player on the Mets’ roster, so his success will play a rather large factor in the team’s success this year. He can be a doubles and triples machine and a big threat on the bases if he gets his feet underneath him against big league competition.

Asdrubal Cabrera will handle second base. He’s been, quietly, quite good for the Mets over the last two seasons, offering a solid offensive approach along with his versatility – he played second and third base as well as shortstop last season. Now 32 years old, Cabrera hit .280/.351/.434 with 14 home runs and 59 RBI last season, which is more than enough when manning a position in the middle of the infield.

At first base, the Mets were able to pluck Adrian Gonzalez off the free agent wire. Gonzalez had gone to the Braves in the Matt Kemp trade, but the Braves quickly dropped him. The 35-year-old had a nightmarish 2017, compiling a .642 OPS in 71 games as he was bothered by back issues throughout the year. He became overshadowed in Los Angeles by Cody Bellinger, who won the NL Rookie of the Year Award, so the Dodgers had no reason to keep him around. Dominic Smith had been another first base option but he suffered a quad injury early in spring training and likely won’t be ready by Opening Day.

Travis d’Arnaud will get the lion’s share of starts behind the plate, backed up by Kevin Plawecki. d’Arnaud provides power, which is always nice to have from a catcher, but he doesn’t hit for average or draw walks, so his batting average and on-base percentage are underwhelming. And while d’Arnaud hasn’t been anything to write home about stopping the running game, he’s regarded as a good pitch framer.

In left field will stand the Mets’ biggest offensive threat, Yoenis Cespedes. Sadly, the slugger was limited to 81 games last year as he battled various leg injuries. When he was in the lineup, he hit .292/.352/.540 with 17 home runs and 42 RBI in 321 plate appearances. Among hitters who have taken at least 1,000 plate appearances since the start of the 2015 season, only 21 have put up a higher weighted on-base average than Cespedes (.368), who finds himself just ahead of Carlos Correa and just behind Corey Seager on that list.

Juan Lagares and Brandon Nimmo will share center field for the time being. Nimmo is having a big spring, putting up a .283/.361/.585 line with eight extra-base hits and 10 RBI in 61 spring plate appearances. He’s likely to bat leadoff against right-handed starters. Lagares isn’t having nearly as good a spring (.483 OPS) but will be in the lineup against lefties and will provide value with his Gold Glove-caliber defense. It’s also quite possible the Mets will trade him as they have gotten some interest lately.

Jay Bruce returns to right field after inking a three-year, $39 million contract in January. The slugger put up a solid .254/.324/.508 line last year between the Mets and Indians with 36 home runs and 101 RBI. Though he struggled – for the most part — in his first go-around with the Mets in the second half of 2016, he’s good for at least 25 home runs and 90 RBI if he can stay healthy, which the soon-to-be 31-year-old has been able to do in recent years.

New manager Mickey Callaway says he plans to use a closer-by-committee which will include Jeurys Familia, Jerry Blevins, A.J. Ramos and Anthony Swarzak. It’s a committee that could certainly have success, but Familia and Ramos are both coming off of down years and Swarzak has been slowed in spring training by a calf injury. The Mets will also have Paul Sewald, Hansel Robles, Rafael Montero, Seth Lugo, and Robert Gsellman providing help from the ‘pen. Wheeler could as well if the Mets determine he can provide more in a relief role than in a starting role.

With all their warts, the Mets do have a competitive roster. The starting rotation has the potential to be really good, led by a now-healthy Syndergaard and followed by deGrom. The offense should be a buoy in the midst of all of the other displeasing variance the Mets will likely wade through during the season. The bullpen won’t be world-beating but will likely not be a serious source of concern given their options. FanGraphs is projecting the Mets to win 82 games while PECOTA has them at 81, which means they’ll be in the mix for the NL Wild Card. That sounds about right to me, but ultimately I think they’ll fall just a bit short of .500.

Prediction: 79-83, third place in NL East.